This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CHNA Loncar China Biopharma ETF (CHNA) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Loncar China Biopharma ETF (NASDAQ:CHNA) 30 days 90 days 365 days Advanced Chart Get CHNA alerts:Sign Up Key Stats Today's Range$13.53▼$13.5350-Day Range$13.53▼$14.7752-Week Range$13.35▼$22.89Volume9 shsAverage Volume538 shsMarket Capitalization$10.56 millionAssets Under Management$3.74 millionDividend Yield0.44%Net Expense Ratio0.79%Aggregate RatingModerate Buy ETF OverviewThe Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.Read More… Loncar China Biopharma ETF ExpensesTypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.57%0.56%0.53%0.53%Other Expenses0.00%0.30%0.48%0.43%0.52%Total Expense0.79%0.70%0.72%0.67%0.71%Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%Net Expense0.79%0.61%0.63%0.61%0.60% Receive CHNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address CHNA ETF News HeadlinesRoundhill China Dragons ETFOctober 5, 2024 | morningstar.comHow investors can get in on the China stock rally with ETFsOctober 4, 2024 | finance.yahoo.comFrom Social Security to Social Prosperity?In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.April 26, 2025 | Paradigm Press (Ad)Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 VaccinesOctober 1, 2024 | markets.businessinsider.comLiaoning Chengda Biotechnology Co. Ltd. ASeptember 24, 2024 | wsj.comBuy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in ChinaAugust 28, 2024 | markets.businessinsider.comSee More Headlines CHNA ETF - Frequently Asked Questions What other stocks do shareholders of Loncar China Biopharma ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Loncar China Biopharma ETF investors own include Alibaba Group (BABA), Baidu (BIDU), Nokia Oyj (NOK), AT&T (T), Tencent (TCEHY), Tesla (TSLA) and Advanced Micro Devices (AMD). Fund Details IssuerExchange Traded Concepts Fund NameLoncar China Biopharma ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHNA Inception Date8/14/2018 Fund ManagerDenise M. Krisko, Habib Moudachirou WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkLoncar China BioPharma Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings89 Fund Statistics Assets Under Management$3.74 million Average Daily Volume$1,200.80 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares780,814Beta1.02 Creation Unit50,000 Creation Fee$750.00 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Top 10 CHNA HoldingsFate Therapeutics (NASDAQ:FATE)Holding Weight: 2.39%Summit Therapeutics (NASDAQ:SMMT)Holding Weight: 2.29%Schrödinger (NASDAQ:SDGR)Holding Weight: 1.85%BioNTech (NASDAQ:BNTX)Holding Weight: 1.75%HUTCHMED (NASDAQ:HCM)Holding Weight: 1.74%Arvinas (NASDAQ:ARVN)Holding Weight: 1.73%iTeos Therapeutics (NASDAQ:ITOS)Holding Weight: 1.71%2seventy bio (NASDAQ:TSVT)Holding Weight: 1.70%Syndax Pharmaceuticals (NASDAQ:SNDX)Holding Weight: 1.67%Exelixis (NASDAQ:EXEL)Holding Weight: 1.66%Full Holdings Details This page (NASDAQ:CHNA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDeepSeek’s Clear and Present DangerDeepSeek — the alleged “$5.5 million” AI project — isn’t an open-source breakthrough. It’s a Trojan horse.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loncar China Biopharma ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Loncar China Biopharma ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CHNA Stock Free CHNA Stock Alerts